Mizuho Securities Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Announces Target Price $124

Futu NewsDec 21 03:31 · Ratings

Analysts' Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS), Zymeworks (ZYME) and Axsome Therapeutics (AXSM)

TipRanksDec 16 14:30 · Ratings

Positive Outlook for Axsome Therapeutics: Buy Rating Backed by Promising AXS-05 Prospects

TipRanksDec 10 14:37 · Ratings

Axsome Therapeutics: Promising Growth Trajectory Justifies Buy Rating Amidst Auvelity's Commercial Success

TipRanksDec 7 23:35 · Ratings

Express News | Axsome Therapeutics Inc : Mizuho Raises Target Price to $124 From $106

BreakingsDec 3 18:35

Morgan Stanley Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Maintains Target Price $125

Futu NewsNov 30 21:32 · Ratings